Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Common side effects of GLP-1 receptor agonists are usually dose-dependent and tend to emerge when you start the medication or increase the dosage
FDA approves Eli Lilly's tirzepatide for weight loss The injection helped certain patients in a recent study lose nearly 60 pounds The Food and Drug Administration (FDA) approved Eli Lilly's drug tirzepatide Wednesday for the treatment of obesity
It's a question our team gets all the time, and for good reason
A new study released Tuesday from commerce-focused solutions company Acosta Group finds that the use of GLP-1 medications for weight loss is influencing consumer behavior beyond diet, affecting purchasing habits, personal care and dining trends, particularly among younger adults
Widmann C, Dolci W, Thorens B
(2019) 208:5765.e4
